Short pages
Jump to navigation
Jump to search
Showing below up to 50 results in range #92,281 to #92,330.
- (hist) Minimizing tissue loss in lower extremity peripheral arterial disease [4,003 bytes]
- (hist) LCOR [4,003 bytes]
- (hist) Granisetron (patient information) [4,004 bytes]
- (hist) Paris syndrome [4,004 bytes]
- (hist) Relaxation technique [4,004 bytes]
- (hist) Monogamy [4,004 bytes]
- (hist) Aicardi-Goutieres syndrome [4,004 bytes]
- (hist) Legg-Calvé-Perthes syndrome (patient information) [4,004 bytes]
- (hist) Hepatocellular carcinoma Echocardiography or Ultrasound [4,004 bytes]
- (hist) Giardiasis epidemiology and demographics [4,004 bytes]
- (hist) WBR269 [4,004 bytes]
- (hist) EVI2B [4,004 bytes]
- (hist) Antimetabolite [4,005 bytes]
- (hist) United States Deputy Secretary of Health and Human Services [4,005 bytes]
- (hist) Unstable angina non ST elevation myocardial infarction factor Xa inhibitors therapy [4,005 bytes]
- (hist) Atrial septal defect pulmonary hypertension [4,005 bytes]
- (hist) Acute promyelocytic leukemia risk factors [4,005 bytes]
- (hist) Turner syndrome MRI [4,005 bytes]
- (hist) Renal papillary necrosis causes [4,005 bytes]
- (hist) PLEKHB2 [4,005 bytes]
- (hist) SPRY4 [4,005 bytes]
- (hist) Peripartum mood disturbances medical therapy [4,005 bytes]
- (hist) Palmitic acid [4,006 bytes]
- (hist) PEEK [4,006 bytes]
- (hist) Meisenheimer complex [4,006 bytes]
- (hist) Upper and lower bounds [4,006 bytes]
- (hist) Abdominal exercise [4,006 bytes]
- (hist) HIST1H2AI [4,006 bytes]
- (hist) Hypersensitivity pneumonitis epidemiology and demographics [4,006 bytes]
- (hist) WBR0684 [4,006 bytes]
- (hist) Subependymal giant cell astrocytoma causes [4,006 bytes]
- (hist) Mast cell leukemia classification [4,006 bytes]
- (hist) PANK4 [4,006 bytes]
- (hist) UBXD2 [4,006 bytes]
- (hist) GINS2 [4,006 bytes]
- (hist) LACTB2 [4,006 bytes]
- (hist) Small nucleolar rna host gene 1 [4,006 bytes]
- (hist) Obturator artery [4,007 bytes]
- (hist) Almitrine [4,007 bytes]
- (hist) Tuberculosis echocardiography or ultrasound [4,007 bytes]
- (hist) Cyclosporiasis risk factors [4,007 bytes]
- (hist) Antiphospholipid syndrome secondary prevention [4,007 bytes]
- (hist) CatSper2 [4,007 bytes]
- (hist) Dactinomycin (patient information) [4,008 bytes]
- (hist) Tarhana [4,008 bytes]
- (hist) False precision [4,008 bytes]
- (hist) New South Wales Department of Health [4,008 bytes]
- (hist) The Living Guidelines: Drug Eluting and Bare Metal Stents View the Current CLASS I Guidelines [4,008 bytes]
- (hist) Marula oil [4,008 bytes]
- (hist) Iberiotoxin [4,008 bytes]